Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00442468 · ClinicalTrials.gov registry record
Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 1,283
- Enrollment target
NCT00442468: Completed study, sponsored by GlaxoSmithKline.
NCT00442468 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 1,283 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00442468 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 1,283 participants
- Enrollment target
Study Summary
The study does not involve testing of a drug (no treatment intervention). The study will will use spirometry (breathing tests) in subjects of 40 years of age and older with a history of cigarette smoking with chronic bronchitis to check their disease status and whether or not they have COPD. Also, study subjects will be asked to complete a questionnaire (to answer a list of questions on paper).
Primary Outcome
Ratio of Forced Expiratory Volume in 1 second (volume of air expelled from the lungs in 1 second) by the Forced Vital Capacity (FVC, the volume of air that can forcibly be blown out after full inspiration) is a spirometric measure (lung function test) used to demonstrate airway obstruction. FEV1/FVC \<=0.7 is used to demonstrate airway obstruction characteristic of chronic obstructive pulmonary disease (COPD).
Interventions
- OTHER Non-interventional study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,283 participants |
| Start Date | 2007-04 |
| Est. Completion | 2007-09 |
What the finished NCT00442468 record still lists
NCT00442468 is an observational study that tracks outcomes without assigning an intervention. Its 1,283 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional study. is the first listed.
NCT00442468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00442468 about?
NCT00442468 is a clinical study titled "Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath". The study does not involve testing of a drug (no treatment intervention). The study will will use spirometry (breathing tests) in subjects of 40 years of age and older with a history of cigarette smoking with chronic bronchitis to check their disease status and whether or not they have COPD. Also, s...
What is the current status of trial NCT00442468?
This trial is currently completed. The enrollment target is 1,283 participants. The study started on 2007-04. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00442468?
The interventions under investigation include: Non-interventional study. (OTHER).
Who is sponsoring clinical trial NCT00442468?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia